作者
Angela Chau,Ming‐Lun Yeh,Pei‐Chien Tsai,Daniel Q. Huang,Sung Eun Kim,Huy N. Trinh,Eileen L. Yoon,Hyun‐Woo Oh,Jae Yoon Jeong,Sang Bong Ahn,Jihyun An,Cheng‐Hao Tseng,Yao‐Chun Hsu,Soung Won Jeong,Yong Kyun Cho,Jae‐Jun Shim,Hyoung Su Kim,Takanori Ito,Sebastián Marciano,Keigo Kawashima,Takanori Suzuki,Tsunamasa Watanabe,Akito Nozaki,Toru Ishikawa,Kaori Inoue,Yuichiro Eguchi,Haruki Uojima,Hiroshi Abe,Hirokazu Takahashi,Makoto Chuma,Masatoshi Ishigami,Joseph Hoang,Mayumi Maeda,Chung‐Feng Huang,Adrián Gadano,Chia‐Yen Dai,Jee‐Fu Huang,Yasuhito Tanaka,Wan‐Long Chuang,Seng Gee Lim,Ramsey Cheung,Ming‐Lung Yu,Dae Won Jun,Mindie H. Nguyen
摘要
It is unclear if there may be sex differences in response to nucleos(t)ide analogs including virologic response (VR), biochemical response (BR), complete response (CR), and hepatocellular carcinoma (HCC) incidence among hepatitis B patients. We compared nucleos(t)ide analog treatment outcomes by sex.